 Clinical Study
September 29, 2024
In this illustrious epoch, wherein the delicate dance of science and nature embarks upon yet another prodigious foray, there emerges from the hallowed halls of LifeVantage Corporation a herald of hope a resplendent beacon illuminating the oft-arduous path of weight management and optimal health. This esteemed establ...
|
Clinical Study
September 29, 2024
In a significant advancement for the treatment of moderate to severe osteoarthritis of the knee, Pacira BioSciences, Inc. (NASDAQ: PCRX), a leader in innovative non-opioid pain management solutions, has announced the forthcoming presentation of compelling 104-week safety and efficacy data surrounding its gene therap...
|
Business Update
September 29, 2024
Piombino Dese, Italy In a significant development for the pharmaceutical, biotechnology, and life sciences sectors, Stevanato Group S.p.A. (NYSE: STVN), a leading global provider in drug containment, delivery, and diagnostic solutions, has announced a strategic alliance with Gerresheimer AG (MDAX: GXI) and SCHOTT...
|
|
 Clinical Study
September 30, 2024
In the esteemed corridors of medical inquiry, CervoMed Inc. has declared its imminent ascendance in the realm of neuropharmaceutical research, revealing plans to deliver late-breaking oral presentations at the forthcoming 17th Clinical Trials on Alzheimer’s Disease Conference (CTAD). Attendees of this venerable ga...
 Announcement
September 30, 2024
In a significant stride toward international expansion, Israeli safety technology company SaverOne has announced its first distribution agreement in the United States. Partnering with Motor Supply Inc. SaverOne is set to introduce its innovative in-vehicle safety solutions to the lucrative American market. This agre...
|
|
Our most Popular Articles
|
Business Update
January 31, 2025
Safe Pro Group Inc. and AI Innovations at SHOT Show 2025 At the SHOT Show 2025 in Aventura, Florida, Safe Pro Group Inc. (NASDAQ: SPAI) made significant waves with its trailblazing AI-powered drone imagery analysis technology. This remarkable innovation, developed by Safe Pro, was highlighted in a video interview co...
|
Merger and Acquisition
January 9, 2024
Mega Matrix Corp.: Expanding the Streaming Empire with the Acquisition of FunVerse Holding Limited
PALO ALTO, Calif., Jan. 08, 2024 - Mega Matrix Corp. (NYSE American: MPU), a leading player in the digital entertainment industry, has recently made a significant move to solidify its dominance in the streaming mar...
|
Clinical Study
April 1, 2025
ORIC Pharmaceuticals Set to Illuminate Investor Conferences Amidst Promising Therapeutic Developments In a strategic move indicative of its commitment to transparency and stakeholder engagement, ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC) has announced its participation in several upcoming investor conferences in Ap...
|
|
|
Company News
|
Clinical Study
September 29, 2024
In a significant advancement for the treatment of moderate to severe osteoarthritis of the knee, Pacira BioSciences, Inc. (NASDAQ: PCRX), a leader in innovative non-opioid pain management solutions, has announced the forthcoming presentation of compelling 104-week safety and efficacy data surrounding its gene therap...
|
Business Update
September 29, 2024
Piombino Dese, Italy In a significant development for the pharmaceutical, biotechnology, and life sciences sectors, Stevanato Group S.p.A. (NYSE: STVN), a leading global provider in drug containment, delivery, and diagnostic solutions, has announced a strategic alliance with Gerresheimer AG (MDAX: GXI) and SCHOTT...
|
Business Update
September 29, 2024
Sage Therapeutics, Inc. has announced the cessation of its collaboration with Biogen regarding the SAGE-324 program, a move that follows the recent unfavorable outcomes of the Phase 2 KINETIC 2 Study. This decision marks a significant turn in the investigational treatment landscape for essential tremor (ET), as SAGE...
|
|
|
Company News
 Business Update
September 29, 2024
|
Company News
 Business Update
September 29, 2024
|
Company News
 Business Update
September 29, 2024
|
More Company News
|
Business Update
September 29, 2024
|
Business Update
September 29, 2024
|
Business Update
September 29, 2024
|
Product Service News
September 29, 2024
|
Product Service News
September 29, 2024
|
Clinical Study
September 29, 2024
|
Clinical Study
September 29, 2024
|
Clinical Study
September 29, 2024
|
Announcement
September 29, 2024
|
Clinical Study
September 29, 2024
|
|
|
|
Related News
|
Business Update
|
Product Service News
|
|
Stocks
|
Announcement
|
|
Business Update
|
Business Update
|
|
|
|
Business News
|
 Clinical Study
In the esteemed corridors of medical inquiry, CervoMed Inc. has declared its imminent ascendance in the realm of neuropharmaceutical research, revealing plans to deliver late-breaking oral presentations at the forthcoming 17th Clinical Trials on Alzheimer’s Disease Conference (CTAD). Attendees of this venerable ga...
|
|
Announcement
In a significant stride toward international expansion, Israeli safety technology company SaverOne has announced its first distribution agreement in the United States. Partnering with Motor Supply Inc. SaverOne is set to introduce its innovative in-vehicle safety solutions to the lucrative American market. This agre...
|
 Partnership
In an era where sustainable practices are not merely desirable but essential, Constellium SE (NYSE: CSTM) is making significant strides in the aluminium recycling sector. The company recently announced a promising partnership with Tesem, a global leader in luxury packaging, aimed at revolutionizing how aluminium is ...
|
 Product Service News
Teledyne Technologies: Pioneering the Future of Machine Vision with Innovative AI Solutions and Collaborative Breakthroughs In an era where automation and precision are paramount, Teledyne Technologies is once again at the forefront of machine vision technology, delivering groundbreaking innovations that promise to ...
|
 Clinical Study
In this illustrious epoch, wherein the delicate dance of science and nature embarks upon yet another prodigious foray, there emerges from the hallowed halls of LifeVantage Corporation a herald of hope a resplendent beacon illuminating the oft-arduous path of weight management and optimal health. This esteemed establ...
|
Our Most Popular Articles
|
 Business Update
Safe Pro Group Inc. and AI Innovations at SHOT Show 2025 At the SHOT Show 2025 in Aventura, Florida, Safe Pro Group Inc. (NASDAQ: SPAI) made significant waves with its trailblazing AI-powered drone imagery analysis technology. This remarkable innovation, developed by Safe Pro, was highlighted in a video interview co...
|
 Merger and Acquisition
Mega Matrix Corp.: Expanding the Streaming Empire with the Acquisition of FunVerse Holding Limited
PALO ALTO, Calif., Jan. 08, 2024 - Mega Matrix Corp. (NYSE American: MPU), a leading player in the digital entertainment industry, has recently made a significant move to solidify its dominance in the streaming mar...
|
|
Clinical Study
ORIC Pharmaceuticals Set to Illuminate Investor Conferences Amidst Promising Therapeutic Developments In a strategic move indicative of its commitment to transparency and stakeholder engagement, ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC) has announced its participation in several upcoming investor conferences in Ap...
|
More News
|
 Clinical Study
In a significant advancement for the treatment of moderate to severe osteoarthritis of the knee, Pacira BioSciences, Inc. (NASDAQ: PCRX), a leader in innovative non-opioid pain management solutions, has announced the forthcoming presentation of compelling 104-week safety and efficacy data surrounding its gene therap...
|
 Business Update
Piombino Dese, Italy In a significant development for the pharmaceutical, biotechnology, and life sciences sectors, Stevanato Group S.p.A. (NYSE: STVN), a leading global provider in drug containment, delivery, and diagnostic solutions, has announced a strategic alliance with Gerresheimer AG (MDAX: GXI) and SCHOTT...
|
 Business Update
Sage Therapeutics, Inc. has announced the cessation of its collaboration with Biogen regarding the SAGE-324 program, a move that follows the recent unfavorable outcomes of the Phase 2 KINETIC 2 Study. This decision marks a significant turn in the investigational treatment landscape for essential tremor (ET), as SAGE...
|
 Business Update
Patterson Companies, Inc. a prominent entity in the distribution of dental and animal health products, has announced a significant move aimed at reinforcing its position in the animal health sector. The company, headquartered in St. Paul, Minnesota, is not only maintaining its robust operations but is also strategic...
|
|
Business Update
Marqeta Expands Its Reach Through Strategic Partnerships with Found and Swiss4, Amid UK Digital Payment Adoption Surge OAKLAND, Calif. Marqeta, the global modern card issuing platform, has unveiled significant partnerships and insights which paint a vivid picture of a rapidly evolving financial landscape. Adding...
|
|
Business Update
As industries around the globe increasingly embrace cutting-edge technologies, strategic partnerships are paving the way for innovative solutions in material processing and asset protection. Laser Photonics Corporation (LPC), listed on NASDAQ as LASE, is leading this charge through its recent collaboration announcem...
|
 Business Update
Clean Energy Fuels Corp. Pioneers Sustainable Transport Solutions with Multiple Groundbreaking Projects Clean Energy to Build First Private Natural Gas Fueling Station for Houston METROClean Energy Fuels Corp. (NASDAQ: CLNE), the industry leader in providing the cleanest fuel for the transportation market, has ann...
|
 Business Update
In a landmark agreement, BlackRock Inc. and Santander have announced the expansion of their partnership in private asset financing, as evidenced by a memorandum of understanding (MoU) signed between the two financial giants. Under this agreement, funds and accounts managed by BlackRock will commit to investing up to...
|
 Business Update
In a significant stride towards a greener future, AECOM, a global leader in infrastructure consulting, has been awarded a pivotal contract to assist the Los Angeles County Metropolitan Transportation Authority (Metro) in its ambitious endeavor to transition its bus fleet to Zero Emission Buses (ZEB). This initiative...
|
 Product Service News
Evaxion Expands Strategic Partnership with MSD to Enhance AI-Driven Vaccine DevelopmentIn a significant advancement for vaccine innovation, Evaxion Biotech A/S, a clinical-stage TechBio company renowned for its pioneering work in AI-Immunology, has bolstered its collaboration with MSD (Merck & Co. Inc.) through a n...
|
 Product Service News
Pasithea Therapeutics has released initial results from its Phase 1 clinical trial for PAS-004, a novel therapeutic candidate aimed at treating advanced cancers, particularly those associated with neurofibromatosis type 1 (NF1) and MAPK pathway alterations. The findings indicate promising safety, tolerability, an...
|
 Clinical Study
Mural Oncology s recent announcement regarding its first virtual investor day has drawn attention to the company s late-stage clinical trials involving nemvaleukin, a novel therapeutic targeted at specific cancer types. This article aims to explore the significance of the anticipated data readouts for these trials,...
|
 Clinical Study
The quest for improved delivery methods for pharmaceutical treatments has led researchers to explore diverse routes, with inhalational therapy gaining momentum due to its potential for localized and efficient drug administration. TFF Pharmaceuticals is at the forefront of this innovative field, as highlighted by two significant developments in their research the exploration of their advanced thin film freezing (TFF) technology for inhalational dry powder formulations and the ongoing clinical trials for their Tacrolimus Inhalation Powder (TFF TAC) aimed at preventing lung transplant rejection. Cutting-Edge Technology: Thin Film Freezing for Inhalational FormulationsRecent research published in the Journal of Drug Delivery Science and Technology showcases the efficacy of TFF Pharmaceuticals proprietary thin film freezing technology in generating inhalational dry powder formulations. One of the key findings of the study emphasizes that TFF s technology results in a more uniform drug distribution within the lungs compared to traditional methods. This is a critical advancement as uneven distribution can diminish therapeutic efficacy and increase the risk of side effects.
|
 Clinical Study
: Gain Therapeutics is set to host a virtual webinar that will address the critical results from its Phase 1 clinical study of GT-02287, a small molecule therapy designed to target glucocerebrosidase (GCase) activity to improve outcomes in patients with Parkinson s disease. The webinar is anticipated to emphasize th...
|
 Announcement
In a rapidly evolving technological landscape, Hut 8 Mining Corp is positioning itself at the confluence of high-performance computing and cryptocurrency mining an ambitious strategy that could redefine its future. Recently, the company entered the GPU-as-a-Service (GPUaaS) market with a significant milestone: the d...
|
 Clinical Study
In an exciting revelation at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024), Centessa Pharmaceuticals unveiled compelling preclinical data for ORX142, a novel Orexin Receptor 2 (OX2R) agonist. This groundbreaking late-breaking poster presentation shines a light on the potential of ORX14...
|
|
|
|
|
